This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which has a ceiling value of $1,002.96, is a delivery order for the supply of EXFORGE 10-320 MG tablets. The contract is a Firm Fixed Price arrangement, with an ultimate completion date of October 18, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
This contract award was not designated with a set-aside requirement, indicating open competition. The DLA, as a defense agency, is responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces, other federal agencies, and partner nations.
Generated 1/16/25, 9:25 AM